Johnson & Johnson (JNJ)
265.77
-4.23
(-1.57%)
USD |
NYSE |
Aug 27, 16:00
266.50
+0.73
(+0.27%)
Pre-Market: 05:34
Johnson & Johnson Market Cap : 640.03B for Aug. 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 27, 2026 | 640.03B |
| August 26, 2026 | 650.22B |
| August 25, 2026 | 657.78B |
| August 24, 2026 | 657.54B |
| August 21, 2026 | 650.80B |
| August 20, 2026 | 643.89B |
| August 19, 2026 | 658.43B |
| August 18, 2026 | 652.89B |
| August 17, 2026 | 631.85B |
| August 14, 2026 | 626.98B |
| August 13, 2026 | 631.15B |
| August 12, 2026 | 628.21B |
| August 11, 2026 | 625.66B |
| August 10, 2026 | 630.50B |
| August 07, 2026 | 624.31B |
| August 06, 2026 | 618.87B |
| August 05, 2026 | 620.34B |
| August 04, 2026 | 613.93B |
| August 03, 2026 | 612.68B |
| July 31, 2026 | 617.35B |
| July 30, 2026 | 616.07B |
| July 29, 2026 | 639.46B |
| July 28, 2026 | 642.35B |
| July 27, 2026 | 640.47B |
| July 24, 2026 | 634.33B |
| Date | Value |
|---|---|
| July 23, 2026 | 624.38B |
| July 22, 2026 | 615.62B |
| July 21, 2026 | 603.53B |
| July 20, 2026 | 599.22B |
| July 17, 2026 | 609.38B |
| July 16, 2026 | 601.98B |
| July 15, 2026 | 594.88B |
| July 14, 2026 | 611.33B |
| July 13, 2026 | 620.77B |
| July 10, 2026 | 618.87B |
| July 09, 2026 | 623.97B |
| July 08, 2026 | 634.33B |
| July 07, 2026 | 643.57B |
| July 06, 2026 | 624.53B |
| July 02, 2026 | 633.46B |
| July 01, 2026 | 611.64B |
| June 30, 2026 | 611.62B |
| June 29, 2026 | 622.13B |
| June 26, 2026 | 612.86B |
| June 25, 2026 | 589.32B |
| June 24, 2026 | 579.99B |
| June 23, 2026 | 575.37B |
| June 22, 2026 | 556.62B |
| June 18, 2026 | 549.64B |
| June 17, 2026 | 563.62B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.107T |
| Merck & Co., Inc. | 369.16B |
| Pfizer Inc. | 159.69B |
| Bristol Myers Squibb Co. | 136.78B |
| Liquidia Corp. | 6.232B |
Market Cap Related Metrics
| PE Ratio | 30.80 |
| PS Ratio | 6.616 |
| Price to Book Value | 7.532 |
| Price to Free Cash Flow | 28.66 |
| Price | 265.77 |
| Earnings Yield | 3.25% |
| Operating PE Ratio | 24.52 |
| Normalized PE Ratio | 28.04 |